Marksans Pharma Q3 Results

  • BSE: 524404
  • NSE: MARKSANS
  • ISIN: INE750C01026
  • Sector: Biotechnology & Drugs
BSE
329-1.45 (-0.44%)
Volume1.34 L
Updated: Fri 11 Sep, 2026 | 15:29:33
NSE
329.95-0.45 (-0.14%)
Volume1.63 M
Updated: Fri 11 Sep, 2026 | 15:29:58
Today: 324.20
333.80
52-Wk: 156.00
349.70

Technical Trends

Long Term
Considers price movement over the last 6 months

Long Term
Not Available

Short Term
Considers price movement over the last 1-2 weeks

Not Available
  • Bearish
  • Moderately Bearish
  • Neutral
  • Moderately Bullish
  • Bullish

Insight: Trends unavailable at the moment.

Q3 Results Highlights

Quarter ended Dec 25

    Note: Comparison is on QoQ basis

    Quarterly - Marksans Pharma Q3 Results

    *All figures in crores except per share values
    Fiscal PeriodDec 25Sep 24QoQ CompDec 23YoY Comp
    Total Operating Expense 618.01525.752.52%475.119.62%
    Depreciation/ Amortization 24.3319.51-9.62%22.0017.59%
    Operating Income 136.42116.1716.02%111.0215.53%
    Net Income 113.2096.7215.22%83.248.26%
    Other Operating Expenses Total 165.47163.691.19%105.766.01%
    Net Income Before Taxes 150.62124.6012.97%112.665.14%
    Total Revenue 754.43641.924.72%586.1310.64%
    Selling/ General/ Admin Expenses Total 111.9984.167.89%74.5326.63%
    Diluted Normalized EPS 2.502.1315.21%1.848.23%

    EQUITY QUICK LINKS

    FROM MARKETS

    RELATED LINKS

    Recommended For You

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe

        Trending Now In Market

          ✕

          Wait for it…

          Log in to our website to save your bookmarks. It'll just take a moment.

          ✕

          Wait for it…

          Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.